Literature DB >> 35601179

Green tea-a new perspective of glaucoma prevention.

Kornelijus Gasiunas1, Saulius Galgauskas1,2.   

Abstract

AIM: To determine how green tea and catechins can affect intraocular pressure (IOP) changes.
METHODS: Totally 43 young volunteers were included in the study. The experiment was held between noon and 2 p.m. Two extracts-green tea and epigallocatechin gallate (EGCG, 400 mg capsules) and placebo (400 mg capsules) were used in the study. Participants were divided into three groups. Green tea extract group (GT group) had 17 subjects, EGCG extract group 17 subjects, control (placebo) group 9 subjects. IOP was measured with the Icare tonometer before and 30min, 1, 1.5, 2h after the consumption of each extract and placebo. Results were analyzed using the IBM SPSS program. Statistical confidence level P<0.05.
RESULTS: The most significant reduction of IOP from the beginning of the experiment was measured after 2h in GT group (left 2.18±3.19 mm Hg, P=0.012; right 2.59±1.97 mm Hg, P<0.000) and after 1h in EGCG extract group (left 2.41±2.98 mm Hg, P<0.004; right 1.94±1.98 mm Hg, P<0.001). In control group no significant changes were measured.
CONCLUSION: People who have increased IOP or risk factors for glaucoma development, could benefit from drinking green tea or its concentrated extracts in moderate doses. International Journal of Ophthalmology Press.

Entities:  

Keywords:  catechin; glaucoma; intraocular pressure; ocular hypertension; tea

Year:  2022        PMID: 35601179      PMCID: PMC9091885          DOI: 10.18240/ijo.2022.05.09

Source DB:  PubMed          Journal:  Int J Ophthalmol        ISSN: 2222-3959            Impact factor:   1.645


  29 in total

Review 1.  Extracellular matrix in the trabecular meshwork: intraocular pressure regulation and dysregulation in glaucoma.

Authors:  Janice A Vranka; Mary J Kelley; Ted S Acott; Kate E Keller
Journal:  Exp Eye Res       Date:  2015-04       Impact factor: 3.467

2.  Combinational enhancing effects of formulation and encapsulation on digestive stability and intestinal transport of green tea catechins.

Authors:  Yu-Ra Son; Jae-Hwan Chung; Sanghoon Ko; Soon-Mi Shim
Journal:  J Microencapsul       Date:  2016-02-15       Impact factor: 3.142

Review 3.  Intraocular pressure: modulation as treatment for glaucoma.

Authors:  Joseph Caprioli; Rohit Varma
Journal:  Am J Ophthalmol       Date:  2011-09       Impact factor: 5.258

Review 4.  Glaucoma.

Authors:  Harry A Quigley
Journal:  Lancet       Date:  2011-03-30       Impact factor: 79.321

Review 5.  The safety of green tea and green tea extract consumption in adults - Results of a systematic review.

Authors:  Jiang Hu; Donna Webster; Joyce Cao; Andrew Shao
Journal:  Regul Toxicol Pharmacol       Date:  2018-03-24       Impact factor: 3.271

6.  Aqueous humor dynamics: a review.

Authors:  Manik Goel; Renata G Picciani; Richard K Lee; Sanjoy K Bhattacharya
Journal:  Open Ophthalmol J       Date:  2010-09-03

7.  Food Inhibits the Oral Bioavailability of the Major Green Tea Antioxidant Epigallocatechin Gallate in Humans.

Authors:  Nenad Naumovski; Barbara L Blades; Paul D Roach
Journal:  Antioxidants (Basel)       Date:  2015-05-27

Review 8.  Bioavailability of Tea Catechins and Its Improvement.

Authors:  Zhuo-Yu Cai; Xu-Min Li; Jin-Pei Liang; Li-Ping Xiang; Kai-Rong Wang; Yun-Long Shi; Rui Yang; Meng Shi; Jian-Hui Ye; Jian-Liang Lu; Xin-Qiang Zheng; Yue-Rong Liang
Journal:  Molecules       Date:  2018-09-13       Impact factor: 4.411

9.  Catechin in Human Health and Disease.

Authors:  Mamoru Isemura
Journal:  Molecules       Date:  2019-02-01       Impact factor: 4.411

10.  TIMP1, TIMP2, and TIMP4 are increased in aqueous humor from primary open angle glaucoma patients.

Authors:  Esther L Ashworth Briggs; Tze'Yo Toh; Rajaraman Eri; Alex W Hewitt; Anthony L Cook
Journal:  Mol Vis       Date:  2015-10-13       Impact factor: 2.367

View more
  1 in total

1.  Impact of Systemic Comorbidities on Ocular Hypertension and Open-Angle Glaucoma, in a Population from Spain and Portugal.

Authors:  Carolina Garcia-Villanueva; Elena Milla; José M Bolarin; José J García-Medina; Javier Cruz-Espinosa; Javier Benítez-Del-Castillo; José Salgado-Borges; Francisco J Hernández-Martínez; Elena Bendala-Tufanisco; Irene Andrés-Blasco; Alex Gallego-Martinez; Vicente C Zanón-Moreno; María Dolores Pinazo-Durán
Journal:  J Clin Med       Date:  2022-09-25       Impact factor: 4.964

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.